pharmacists doctors web

NCPA, NASPA offer resource to help pharmacists implement point-of-care testing

Point-of-care testing services enhance patient care, support pharmacy revenue.

The NCPA Innovation Center, a supporting organization of the National Community Pharmacists Association, has teamed up with the National Alliance of State Pharmacy Associations to develop and release a new guidance document. The guidance document is designed to help community pharmacy teams with their point-of-care testing services. This work was completed with support from QuidelOrtho Corporation.

POCT involves screenings and tests that produce rapid, reliable results to aid in identifying, monitoring and treating acute infections or chronic diseases. In addition to enhancing patient care and improving health, it provides an excellent opportunity for pharmacies to expand revenue-generating services. The new document“A Guide to Implementing Point-of-Care Testing Services in Community Pharmacy”was developed to broadly help with setting up and providing these services, marketing them in their communities, and navigating reimbursement. Pharmacy teams should consult with their state pharmacy association or board of pharmacy for information on specific laws and regulations.

[Read more: Pharmacy orgs laud DIR fee and pharmacy access bill as vital for PBM reform]

“Point-of-care testing has become increasingly important as community pharmacies seek to fill gaps in primary care and develop diversified revenue streams,” said Lea Wolsoncroft, president of NCPA. “This implementation guide provides an A-Z roadmap for pharmacists interested in offering this service in their practice setting and will be a valuable tool in doing so most effectively.”

“NASPA was excited to partner with the NCPA Innovation Center in creating this important resource for community pharmacists. Pharmacists’ accessibility and expertise make them well positioned to assess and treat minor, nonchronic health conditionsa significant benefit for our communities,” said Krystalyn Weaver, executive vice president and CEO of NASPA.

[Read more: NCPA releases latest survey on drug supply chain, staffing]

This ad will auto-close in 10 seconds